Suppr超能文献

保留新驱虫药:一种在疗效和/或线虫聚集度高时估算粪便卵计数减少试验 (FECRT) 置信限的简单方法。

Preserving new anthelmintics: a simple method for estimating faecal egg count reduction test (FECRT) confidence limits when efficacy and/or nematode aggregation is high.

机构信息

Murdoch University, School of Veterinary and Biomedical Sciences, South Street, Murdoch, WA 6150, Australia.

出版信息

Vet Parasitol. 2012 May 4;186(1-2):79-92. doi: 10.1016/j.vetpar.2011.11.049. Epub 2011 Nov 20.

Abstract

As it has been 30 years since a new anthelmintic class was released, it is appropriate to review management practices aimed at slowing the development of anthelmintic resistance to all drug classes. Recommendations to delay anthelmintic resistance, provide refugia and the use of a simulation model were reviewed to find optimum treatment strategies that maintain nematode control. Simulated Australian conditions indicated that a common successful low-risk treatment program was a rapid rotation between a "triple-combination" product (benzimidazole+levamisole+abamectin) and a new high-efficacy drug (monepantel). Where Haemonchus contortus was a threat, moxidectin was required at critical times because of its persistent activity against this parasite. Leaving up to 4% of adult sheep untreated provided sufficient "refugia" for non-selected worms to reduce the risk of selecting for anthelmintic resistance without compromising nematode control. For a new anthelmintic, efficacy estimated by faecal egg count reduction (FECR) is likely to be at or close to 100%, however using current methods the 95% confidence limits (CL) for 100% are incorrectly determined as 100%. The fewer eggs counted pre-treatment, the more likely an estimate of 100% will occur, particularly if the true efficacy is >90%. A novel way to determine the lower-CL (LCL) for 100% efficacy is to reframe FECR as a binomial proportion, i.e. define: n and x as the total number of eggs counted (rather than eggs per gram of faeces) for all pre-treatment and post-treatment animals, respectively; p the proportion of resistant eggs is p = x/n and percent efficacy is 100 ×(1-p) (assuming equal treatment group sizes and detection levels, pre- and post-treatment). The LCL is approximated from the cumulative inverse beta distribution by: 95%LCL=100 ×(1-(BETAINV(0.975, x+1, n-x+1))). This method is simpler than the current method, independent of the number of animals tested, and demonstrates that for 100% efficacy at least 37 eggs (not eggs per gram) need to be counted pre-treatment before the LCL can exceed 90%. When nematode aggregation is high, this method can be usefully applied to efficacy estimates lower than 100%, and in this case the 95% upper-CL (UCL) can be estimated by: 95% UCL = 100 ×(1((BETAINV(0.025, x+1, n-x+1))), with the LCL approximated as described above. A simulation study to estimate the precision and accuracy of this method found that the more conservative 99%CL was optimum; in this case 0.975 and 0.025 are replaced by 0.995 and 0.005 to estimate the LCL and UCL, respectively.

摘要

由于自上一种新的驱虫药问世以来已经过去了 30 年,因此有必要审查旨在减缓所有驱虫药耐药性发展的管理实践。本文回顾了延缓驱虫药耐药性、提供避难所和使用模拟模型的建议,以寻找保持线虫控制的最佳治疗策略。模拟的澳大利亚条件表明,一种常见的成功低风险治疗方案是在“三联组合”产品(苯并咪唑+左旋咪唑+阿维菌素)和新的高效药物(莫昔克丁)之间快速轮换。在存在捻转血矛线虫威胁的情况下,由于其对这种寄生虫的持续活性,莫昔克丁在关键时刻是必需的。让多达 4%的成年绵羊未经治疗,为未选择的蠕虫提供了足够的“避难所”,从而降低了选择驱虫药耐药性的风险,而不会影响线虫控制。对于一种新的驱虫药,通过粪便卵计数减少(FECR)估计的疗效可能接近或达到 100%,然而,使用当前方法,100%的 95%置信限(CL)被错误地确定为 100%。在治疗前计数的卵越少,估计 100%的可能性就越大,特别是如果真实疗效>90%。一种确定 100%疗效的较低置信限(LCL)的新方法是将 FECR 重新定义为二项式比例,即:n 和 x 分别为所有治疗前和治疗后动物的总卵数(而不是每克粪便中的卵数);p 是耐药卵的比例,p = x/n,百分效率为 100×(1-p)(假设治疗组大小和检测水平相等,治疗前和治疗后)。LCL 可以通过累积逆 beta 分布近似得到:95%LCL=100×(1-(BETAINV(0.975,x+1,n-x+1)))。这种方法比当前方法更简单,与测试的动物数量无关,并证明在至少 37 个卵(而不是每克粪便中的卵数)需要在治疗前计数之前,LCL 才能超过 90%。当线虫聚集度较高时,这种方法可用于低于 100%的疗效估计,在这种情况下,可以通过以下方法估计 95%上限置信限(UCL):95%UCL=100×(1-(BETAINV(0.025,x+1,n-x+1))),其中 LCL 可以近似如上所述。一项估计该方法精度和准确性的模拟研究发现,更保守的 99%CL 是最佳的;在这种情况下,0.975 和 0.025 分别用 0.995 和 0.005 替换,以分别估计 LCL 和 UCL。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验